image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

TMI Trader Portfolio 2 - September '21

September 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

A decent month for shares despite the Delta variant squeezing investors into risk-off mode even though vaccine uptake continues to make headway. Amidst that backdrop, the 3.2% gain by TP2 is a respectable return. Most of that gain came from Reach, which astonishingly rose 60% at one point to a new high of 419.5p after results beat expectations and the share price saw it promoted into the FTSE-250 on 6 August. In bullish fashion, management launched a 25% operating margin target, increased writing staff to 10-year highs and have seen digital overtake print advertising for the first time. How high can its rating go? Digital media rival Future, 3562p, trades on a PE of 28.8, which would translate into a Reach share price of over ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X